Saturday , December 15 2018
Home / Diseases / Global Rare Disease Diagnostics Market Analysis and Forecast, 2018-2025: Focus on Genetic Diseases, Service Providers, Competitive Landscape, and Country – ResearchAndMarkets.com

Global Rare Disease Diagnostics Market Analysis and Forecast, 2018-2025: Focus on Genetic Diseases, Service Providers, Competitive Landscape, and Country – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Rare Disease Diagnostics Market: Focus on Genetic Diseases, Service
Providers, Competitive Landscape, and Country – Analysis and Forecast,
2018-2025”
report has been added to ResearchAndMarkets.com’s
offering.

The global rare disease diagnostics market was valued $45.18 billion in
2017 and is anticipated to reach $86.15 billion by 2025

The global rare disease diagnostics market (by disease type) is
currently dominated by hematology and oncology segment. The contribution
of hematology and oncology segment was valued $10.0 billion in 2017 and
is expected to reach $20.5 billion by 2025, witnessing a CAGR of 9.35%
during the forecast period.

Factors such as high incidence of rare diseases, presence of large
numbers of research and development facilities for rare diseases,
significant number of rare disease registries, high diagnosis rare of
rare diseases in countries of North America, and extensive investments
in different therapeutic areas are driving the growth of the North
America rare disease diagnostics market. However, the Asia Pacific
region is expected to register the highest CAGR of 9.22% during the
forecast period 2018-2025.

Key Topics Covered:

Executive Summary

1 Market Overview

2 Market Dynamics

3 Competitive Landscape

4 Industry Insights

5 Global Rare Disease Diagnostics Market (by Disease Type)

6 Global Rare Disease Diagnostics Market (by Test Type)

7 Global Rare Disease Diagnostics Market (by Trait)

8 Global Rare Disease Diagnostics Market (by Age Group)

9 Global Rare Disease Diagnostics Market (by End User)

10 Global Rare Disease Diagnostics Market (by Region)

11 North America Rare Disease Diagnostics Market

12 Europe Rare Disease Diagnostics Market

13 Latin America Rare Disease Diagnostics Market

14 Asia Pacific Rare Disease Diagnostics Market

15 MEA Rare Disease Diagnostics Market

16 Company Profiles

  • 23andMe, Inc.
  • 3billion, Inc.
  • BGI
  • Centogene A.G.
  • Eurofins Scientific
  • GENEWIZ
  • Illumina Inc.
  • InDepth Genomics
  • Laboratory Corporation of America
  • Partek, Inc.
  • PerkinElmer, Inc.
  • Personal Genome Diagnostics, Inc.
  • QIAGEN N.V.
  • Retrophin, Inc.
  • Strand Life Sciences Pvt Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/9zrdpd/global_rare?w=4


Source link

The Ultimate Green Store

About

Check Also

Why Ex-CDC Head Should Have Been In Prison

Ex-CDC head, Dr. Brenda Fiztgerald bows in shame when her corruption came to light. Time …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.